Study identifier:D9615C00019
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Randomised, Double-Blind, Placebo Controlled Explorative Study to Investigate the Efficacy and Safety of Esomeprazole in the Prevention of Post Operative Nausea and Vomiting
gastrointestinal diseases
Phase 2
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|